LAMIAPHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LAMIAPHARM
Largest movements
- Cash +€29,093
up €29,093 (+738.5%), from €3,939 to €33,032
mainly Net result for the year (+€44,992) and Other debts (+€13,250)
- Tangible fixed assets +€23,035
new in 2025: €23,035
- Receivables within one year +€11,026
up €11,026 (+710.2%), from €1,552 to €12,578
- Profit (loss) carried forward +€44,992
up €44,992, from -€114 to €44,878
- Other debts +€13,250
new in 2025: €13,250
- Tax, wage and social debts +€6,866
new in 2025: €6,866
- Trade debts -€1,955
down €1,955 (-75.0%), from €2,605 to €650
- Gross operating margin +€59,027
up €59,027, from -€114 to €58,913
- Taxes +€12,756
new in 2025: €12,756
- Depreciation +€1,126
new in 2025: €1,126
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,492 | €68,645 | +€63,153 | +1150.0% |
| Fixed assets | 21/28 | - | €23,035 | +€23,035 | |
| Tangible fixed assets | 22/27 | - | €23,035 | +€23,035 | |
| Furniture and vehicles | 24 | - | €23,035 | +€23,035 | |
| Current assets | 29/58 | €5,492 | €45,610 | +€40,118 | +730.5% |
| Amounts receivable within one year | 40/41 | €1,552 | €12,578 | +€11,026 | +710.2% |
| Trade receivables | 40 | €1,552 | €12,578 | +€11,026 | +710.2% |
| Cash at bank and in hand | 54/58 | €3,939 | €33,032 | +€29,093 | +738.5% |
| Total equity and liabilities | 10/49 | €5,492 | €68,645 | +€63,153 | +1150.0% |
| Equity | 10/15 | €2,886 | €47,878 | +€44,992 | +1558.9% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€114 | €44,878 | +€44,992 | |
| Amounts payable | 17/49 | €2,605 | €20,766 | +€18,161 | +697.0% |
| Amounts payable within one year | 42/48 | €2,605 | €20,766 | +€18,161 | +697.0% |
| Trade debts | 44 | €2,605 | €650 | -€1,955 | -75.0% |
| Suppliers | 440/4 | €2,605 | €650 | -€1,955 | -75.0% |
| Taxes, remuneration and social security | 45 | - | €6,866 | +€6,866 | |
| Taxes | 450/3 | - | €6,866 | +€6,866 | |
| Other amounts payable | 47/48 | - | €13,250 | +€13,250 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €1,126 | +€1,126 | |
| Gross operating margin | 9900 | -€114 | €58,913 | +€59,027 | |
| Operating profit (loss) | 9901 | -€114 | €57,787 | +€57,901 | |
| Financial charges | 65/66B | - | €39 | +€39 | |
| Recurring financial charges | 65 | - | €39 | +€39 | |
| Profit (loss) for the period before taxes | 9903 | -€114 | €57,748 | +€57,862 | |
| Income taxes | 67/77 | - | €12,756 | +€12,756 | |
| Profit (loss) for the period | 9904 | -€114 | €44,992 | +€45,106 | |
| Profit (loss) for the period to be appropriated | 9905 | -€114 | €44,992 | +€45,106 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.